Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the first application of REMspace technology outside of research by December 31, 2025?
Therapeutic Use • 25%
Gaming Industry • 25%
Educational Tool • 25%
Other • 25%
Official announcements from REMspace or involved entities
REMspace Achieves Two-Way Communication in Lucid Dreaming
Oct 11, 2024, 07:44 PM
In a groundbreaking development, California-based neurotech startup REMspace claims to have achieved the first two-way communication between individuals during lucid dreaming. This scientific achievement, announced recently, could open new avenues for future dream research. The technology, which allows people to communicate while dreaming, represents a significant advancement in the field of neurotechnology. This world first breakthrough could revolutionize our understanding of dreams.
View original story
Gaming • 25%
Medical diagnostics • 25%
Communication tools • 25%
Other • 25%
Communication enhancement for ALS patients • 25%
Cognitive enhancement for general users • 25%
Control of tech devices like Apple Vision Pro • 25%
Medical research and trials • 25%
OneWeb • 25%
Amazon Kuiper • 25%
SpaceX Starlink • 25%
Other • 25%
Harvard University • 25%
Stanford University • 25%
MIT • 25%
University of California, Berkeley • 25%
Healthcare • 25%
Education • 25%
Communication • 25%
Other • 25%
Natural Language Processing • 25%
Computer Vision • 25%
Robotics • 25%
Other • 25%
Smartphones • 25%
Data Centers • 25%
AI Models • 25%
Other • 25%
Healthcare • 25%
Finance • 25%
Automotive • 25%
Retail • 25%
Commercial aviation • 25%
Military applications • 25%
Research and development • 25%
Other • 25%
Pharmaceuticals • 25%
Agriculture • 25%
Environmental Science • 25%
Bioengineering • 25%
American Battery Technology Co. • 25%
Albemarle • 25%
Forge Battery • 25%
Group14 Technologies • 25%
Financial services • 25%
Healthcare • 25%
Supply chain • 25%
Other • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
United States • 25%
Other • 25%
China • 25%
European Union • 25%